Pharsight

GLENMARK SPECIALTY SA PATENTS FACING OPPOSITIONS

Top patents of GLENMARK SPECIALTY SA facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3043773B1 30 Jun, 2021 Stable Fixed Dose Pharmaceutical Composition Comprising Mometasone And Olopatadine Sep, 2034 1